Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the ...
PharmaTher Holdings (CSE:PHRM) is on track to resubmit information to the U.S. Food and Drug Administration (FDA) by the end ...
'Skeletal editing' promises new, personalised drugs at fraction of cost — an Indian is pioneering it
At the University of Oklahoma, Prof. Indrajeet Sharma is leading a team of scientists that is working on a ‘skeletal editing’ ...
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
Shares of Axsome Therapeutics ( AXSM 20.22%) are flying higher on Monday. The company's stock is up 24.7% as of 1:10 p.m. ET, ...
Prince Harry has lived in the US for over four years, but many questions have been raised as to the validity of his visa due ...
Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...
Research and Development (R&D) Expenses: R&D expenses were $82.8 million for the fourth quarter of 2024, compared to $77.5 million for the fourth quarter of 2023, and $301.3 million for the full year ...
Total operating expenses for the fourth quarter of 2024 were $287 million, including non-cash stock-based compensation of $40 ...
US President Donald Trump has ruled out deporting Prince Harry from the United States, despite ongoing litigation questioning ...
They are important niches to the scientists who can now solve previously unsolvable problems, but they may not constitute ...
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results